Growth Hormone Secretion and Regulation

 PHARMACOLOGY

 

Growth Hormone Secretion and Regulation

 

Growth hormone is secreted from somatotrophs in the anterior pituitary. Multiple feedback loops are present in normal regulation of hGH secretion (Casanueva, 1992; Giustina and Veldhuis 1998) (Fig. 3). Growth hormone release from the pituitary is regulated by a “short loop” of two coupled hypothalamic peptides—a stimulatory peptide,


growth hormone releasing hormone (GHRH) and an inhibitory peptide, somatostatin. GHRH and somatostatin are, in turn, regulated by neuronal input to the hypothalamus and the GH secretagogue, ghrelin (Kojima et al., 2001). There is possibly also an “ultrashort loop” in which hGH release is feedback regulated by growth hormone receptors present on the somatotrophs of the pituitary them-selves. Growth hormone secretion is also regulated by a “long loop” of peripheral signals including insulin-like growth factor (IGF-1) and other modulators.

 

 

Growth hormone secretion changes during human development, with the highest production rates observed during gestation and puberty (Brook and Hindmarsh 1992; Guistina and Veldhuis, 1998). Growth hormone production de-clines approximately 10 to 15% each decade from age 20 to 70 years. Endogenous hGH secretion also varies with sex, nutritional status, obesity, physical activity, and in a variety of disease states. Endogenous hGH is secreted in periodic bursts over a 24 hour period with great variability in burst frequency, amplitude and duration. There is little detectable hGH released from the pituitary between bursts. The highest endogenous hGH serum con-centrations of 10 to 30 ng/mL usually occur at night when the secretory bursts are largest and most frequent.

Comments

Post a Comment

Popular posts from this blog

Adenoviral Vectors - Viral Vectors for Gene Transfer

Image
  Viral Vectors for Gene Transfer   Viruses, natural parasites that efficiently enter cellular targets and hijack cellular machinery for propagation, are currently the most effective vectors for gene therapy. Approximately 70% of all gene therapy clinical trials employ viral vectors (Table 4). Many viruses with divergent properties have been devel-oped for gene transfer. Retroviruses, adenoviruses and adeno-associated viruses (AAVs) are the most extensively studied to date. Characteristics of each are summarized in Table 5.   Adenoviral Vectors Biology   Adenoviruses are non-enveloped, lytic, DNA viruses with a linear double-stranded genome and icosahedral symmetry. Since the isolation of the first human adenovirus in 1953 from tonsils and adenoid tissue (Rowe, 1953), 50 additional serotypes have been identified and grouped into six species (A–F) based on genome size, composition and homology, hemag-glutinating properties and oncogenicity in rodents. Because the subg...
Read more

Direct Binding to Non-Nucleic Acids

Image
  DIRECT BINDING TO NON-NUCLEIC ACIDS The ability of nucleic acids to fold into complex three-dimensional structures through regions of (partial) complementarity allows them to bind to virtually any molecule with nano- to picomolar affinity (Proske et al., 2005). This high affinity is supported by data on their extreme specificity. A nucleic acid sequence specifically binding theophylline has a million times higher affinity for theophylline than caffeine, mole-cules which differ by only one methyl group.   Aptamers/Riboswitches   Aptamers and riboswitches are single-stranded ONs of either DNA or RNA, generally about 60 nucleotides long, which fold into well-defined three-dimensional structures. They bind to their target molecule by complementary shape interactions accompanied by charge and hydrophobic interactions and hydrogen bridges. The target can be small molecules or macromolecules. Aptamers are isolated artificially, whereas riboswitches occur naturally (Tucker and ...
Read more

Uptake - Immunological Principles of Vaccines

  Uptake   Every immune reaction against a pathogen starts with its uptake by specialized phagocytic cells in the infected tissue. These cells carry receptors on their surface; pattern-recognition receptors (PRRs) that recognize common features of pathogens called pathogen associated molecular patterns (PAMPs). Binding of PAMPs to these PRRs results in phagocy-tosis of the pathogens. Examples of PRRs are toll-like receptors (TLRs), scavenger receptors and C-type lectins (Table 2). TLRs consist of a family of receptors, with each member recognizing different patterns on the surface of pathogens ( Akira et al., 2006). TLRs canbe found on many cells including macrophages and dendritic cells (DCs). DCs can also engulf materials from their extracellular environment by a receptor independent process called micropinocytosis.
Read more